LTC4

Ltc4 is a lipid of Fatty Acyls (FA) class. Ltc4 is associated with abnormalities such as Asthma, Eosinophilia, Pulmonary Eosinophilia, Pneumonia and Cardiovascular Diseases. The involved functions are known as Signal, Gene Expression, Stimulus, Signal Transduction and Metabolic Inhibition. Ltc4 often locates in Plasma membrane, Cytoplasm, Back, Cytoplasmic and Tissue membrane. The associated genes with LTC4 are STIM1 gene, ABCC2 gene, CD9 gene, Mutant Proteins and Amino Acids, Aromatic. The related lipids are glycolithocholate.

Cross Reference

Introduction

To understand associated biological information of LTC4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTC4?

LTC4 is suspected in Pneumonia, Asthma, Pulmonary Eosinophilia, Eosinophilia, Cardiovascular Diseases, Disintegration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTC4

MeSH term MeSH ID Detail
Phlebitis D010689 1 associated lipids
Pseudoxanthoma Elasticum D011561 2 associated lipids
Neointima D058426 3 associated lipids
Eosinophilic Esophagitis D057765 3 associated lipids
Common Bile Duct Diseases D003137 3 associated lipids
Cestode Infections D002590 3 associated lipids
Hyperbilirubinemia, Hereditary D006933 3 associated lipids
Wounds, Nonpenetrating D014949 4 associated lipids
Insect Bites and Stings D007299 4 associated lipids
Picornaviridae Infections D010850 4 associated lipids
Per page 10 20 50 100 | Total 75

PubChem Associated disorders and diseases

What pathways are associated with LTC4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTC4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTC4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTC4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTC4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTC4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTC4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTC4

Download all related citations
Per page 10 20 50 100 | Total 1173
Authors Title Published Journal PubMed Link
Cederholm T et al. Impaired leukotriene C4 generation in granulocytes from protein-energy malnourished chronically ill elderly. 2000 J. Intern. Med. pmid:10886494
Horikawa T et al. Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis. 1995 J. Invest. Dermatol. pmid:7530272
Kobayashi H et al. Urinary trypsin inhibitor reduces the release of histamine from rat peritoneal mast cells. 1998 J. Lab. Clin. Med. pmid:9579392
Gibbs BF et al. Regulation of mediator secretion in human basophils by p38 mitogen-activated protein kinase: phosphorylation is sensitive to the effects of phosphatidylinositol 3-kinase inhibitors and calcium mobilization. 2002 J. Leukoc. Biol. pmid:12149431
Oliveira SH et al. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8. 2002 J. Leukoc. Biol. pmid:12050188
Inoue T et al. Nitric Oxide positively regulates Ag (I)-induced Ca(2+) influx and mast cell activation: role of a Nitric Oxide Synthase-independent pathway. 2009 J. Leukoc. Biol. pmid:19706839
Raible DG Erythrocytes increase leukotriene C4 release from human eosinophils: characterization and examination of possible mechanisms. 1994 J. Leukoc. Biol. pmid:8027672
Gibbs BF and Grabbe J Inhibitors of PI 3-kinase and MEK kinase differentially affect mediator secretion from immunologically activated human basophils. 1999 J. Leukoc. Biol. pmid:10380914
Blanchet MR et al. Modulation of eosinophil activation in vitro by a nicotinic receptor agonist. 2007 J. Leukoc. Biol. pmid:17289799
Hom JT et al. The amyloidogenic peptide human amylin augments the inflammatory activities of eosinophils. 1995 J. Leukoc. Biol. pmid:7595053
Malaviya R and Abraham SN Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. 2000 J. Leukoc. Biol. pmid:10857857
Tsuruta R et al. Soluble vascular cell adhesion molecule (VCAM)-Fc fusion protein induces leukotriene C4 secretion in platelet-activating factor-stimulated eosinophils. 1999 J. Leukoc. Biol. pmid:9886248
Rossi A et al. Up-regulation of prostaglandin biosynthesis by leukotriene C4 in elicited mice peritoneal macrophages activated with lipopolysaccharide/interferon-{gamma}. 2005 J. Leukoc. Biol. pmid:16046553
Mayatepek E et al. Synthesis and metabolism of leukotrienes in gamma-glutamyl transpeptidase deficiency. 2004 J. Lipid Res. pmid:14754911
Dichlberger A et al. Adipose triglyceride lipase regulates eicosanoid production in activated human mast cells. 2014 J. Lipid Res. pmid:25114172
Sjölinder M et al. Characterization of a leukotriene C4 export mechanism in human platelets: possible involvement of multidrug resistance-associated protein 1. 1999 J. Lipid Res. pmid:10064732
Lukic A et al. Pulmonary epithelial cancer cells and their exosomes metabolize myeloid cell-derived leukotriene C4 to leukotriene D4. 2016 J. Lipid Res. pmid:27436590
Seno K et al. Pyrrolidine inhibitors of human cytosolic phospholipase A(2). 2000 J. Med. Chem. pmid:10737736
Seres I et al. The association between angiotensin II-induced free radical generation and membrane fluidity in neutrophils of patients with metabolic syndrome. 2006 J. Membr. Biol. pmid:17546512
Becher UM et al. Inhibition of leukotriene C4 action reduces oxidative stress and apoptosis in cardiomyocytes and impedes remodeling after myocardial injury. 2011 J. Mol. Cell. Cardiol. pmid:21112334
Zhou M et al. In vivo intranasal anti-CD23 treatment inhibits allergic responses in a murine model of allergic rhinitis. 2013 J. Mol. Histol. pmid:23377922
Eaton A et al. Cysteinyl leukotriene signaling through perinuclear CysLT(1) receptors on vascular smooth muscle cells transduces nuclear calcium signaling and alterations of gene expression. 2012 J. Mol. Med. pmid:22527886
Xiang Y et al. Anti-inflammatory effect of acetylpuerarin on eicosanoid signaling pathway in primary rat astrocytes. 2014 J. Mol. Neurosci. pmid:24026619
Wu L et al. Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury. 2012 J. Mol. Neurosci. pmid:22661361
Fujii R et al. Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells. 1994 J. Natl. Cancer Inst. pmid:7966417
Farias SE et al. Transcellular biosynthesis of cysteinyl leukotrienes in rat neuronal and glial cells. 2007 J. Neurochem. pmid:17711426
Constable AL et al. DMSO induction of the leukotriene LTC4 by Lewis rat Schwann cells. 1999 J. Neurol. Sci. pmid:10202977
Black P et al. Chemotherapy in experimental brain tumor, part 2: pretreatment with leukotriene C4 prolongs survival. 1998 J. Neurooncol. pmid:9525821
Hashizume K and Black KL Increased endothelial vesicular transport correlates with increased blood-tumor barrier permeability induced by bradykinin and leukotriene C4. 2002 J. Neuropathol. Exp. Neurol. pmid:12152787
Rao AM et al. CDP-choline: neuroprotection in transient forebrain ischemia of gerbils. 1999 J. Neurosci. Res. pmid:10561698
Paoletti P et al. CSF leukotriene C4 following subarachnoid hemorrhage. 1988 J. Neurosurg. pmid:3418380
Black KL et al. Enzymatic barrier protects brain capillaries from leukotriene C4. 1994 J. Neurosurg. pmid:7931622
Dhillon HS et al. Regional generation of leukotriene C4 after experimental brain injury in anesthetized rats. 1996 J. Neurotrauma pmid:9002063
Farias S et al. Injury-related production of cysteinyl leukotrienes contributes to brain damage following experimental traumatic brain injury. 2009 J. Neurotrauma pmid:19886806
Cao D et al. Chronic administration of ethyl docosahexaenoate reduces gerbil brain eicosanoid productions following ischemia and reperfusion. 2006 J. Nutr. Biochem. pmid:16098734
Cruz JR et al. Fecal excretion of leukotriene C4 during human disease due to Shigella dysenteriae. 1995 J. Pediatr. Gastroenterol. Nutr. pmid:7714683
Shimizu T et al. Leukotriene B4 and C4 metabolism in small intestine mucosa of children with celiac disease. 1995 J. Pediatr. Gastroenterol. Nutr. pmid:8583294
Ebersole JL et al. Inflammatory mediators and immunoglobulins in GCF from healthy, gingivitis and periodontitis sites. 1993 J. Periodont. Res. pmid:8263728
Abad MJ et al. Effects of furocoumarins from Cachrys trifida on some macrophage functions. 2001 J. Pharm. Pharmacol. pmid:11518028
Fernández MA et al. New insights into the mechanism of action of the anti-inflammatory triterpene lupeol. 2001 J. Pharm. Pharmacol. pmid:11732756
Munoz NM et al. Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4. 1994 J. Pharmacol. Exp. Ther. pmid:8301549
Sathirakul K et al. Multiple transport systems for organic anions across the bile canalicular membrane. 1994 J. Pharmacol. Exp. Ther. pmid:8301595
Gissurarson SR et al. Effect of lobaric acid on cysteinyl-leukotriene formation and contractile activity of guinea pig taenia coli. 1997 J. Pharmacol. Exp. Ther. pmid:9023290
Brochu-Bourque A et al. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor. 2011 J. Pharmacol. Exp. Ther. pmid:20966037
Aoki M et al. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor. 2001 J. Pharmacol. Exp. Ther. pmid:11504812
Zhang XC et al. Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. 2007 J. Pharmacol. Exp. Ther. pmid:17483291
Masereeuw R et al. Active lucifer yellow secretion in renal proximal tubule: evidence for organic anion transport system crossover. 1999 J. Pharmacol. Exp. Ther. pmid:10215693
Loe DW et al. Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). 2000 J. Pharmacol. Exp. Ther. pmid:10773025
Rius M et al. ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4). 2008 J. Pharmacol. Exp. Ther. pmid:17959747
Rao NL et al. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. 2007 J. Pharmacol. Exp. Ther. pmid:17371808